1. Home
  2. VERU vs COE Comparison

VERU vs COE Comparison

Compare VERU & COE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • COE
  • Stock Information
  • Founded
  • VERU 1971
  • COE 2011
  • Country
  • VERU United States
  • COE Singapore
  • Employees
  • VERU N/A
  • COE N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • COE Other Consumer Services
  • Sector
  • VERU Health Care
  • COE Real Estate
  • Exchange
  • VERU Nasdaq
  • COE Nasdaq
  • Market Cap
  • VERU 108.8M
  • COE 115.0M
  • IPO Year
  • VERU 1990
  • COE 2016
  • Fundamental
  • Price
  • VERU $0.57
  • COE $19.78
  • Analyst Decision
  • VERU Strong Buy
  • COE
  • Analyst Count
  • VERU 4
  • COE 0
  • Target Price
  • VERU $4.00
  • COE N/A
  • AVG Volume (30 Days)
  • VERU 6.2M
  • COE 19.2K
  • Earning Date
  • VERU 02-13-2025
  • COE 03-21-2025
  • Dividend Yield
  • VERU N/A
  • COE N/A
  • EPS Growth
  • VERU N/A
  • COE N/A
  • EPS
  • VERU N/A
  • COE N/A
  • Revenue
  • VERU $16,886,419.00
  • COE $41,924,000.00
  • Revenue This Year
  • VERU N/A
  • COE N/A
  • Revenue Next Year
  • VERU N/A
  • COE N/A
  • P/E Ratio
  • VERU N/A
  • COE N/A
  • Revenue Growth
  • VERU 22.46
  • COE 69.79
  • 52 Week Low
  • VERU $0.49
  • COE $6.00
  • 52 Week High
  • VERU $1.92
  • COE $25.70
  • Technical
  • Relative Strength Index (RSI)
  • VERU 44.48
  • COE 45.81
  • Support Level
  • VERU $0.49
  • COE $19.55
  • Resistance Level
  • VERU $0.56
  • COE $25.70
  • Average True Range (ATR)
  • VERU 0.05
  • COE 1.57
  • MACD
  • VERU 0.00
  • COE -0.34
  • Stochastic Oscillator
  • VERU 63.62
  • COE 8.36

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About COE 51Talk Online Education Group

51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand.

Share on Social Networks: